moxalactam has been researched along with cefaclor anhydrous in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandsch, M; Luckner, P | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Arai, S; Fukuchi, H; Kimura, M; Kitaura, T; Miyake, K; Tsukiai, S | 2 |
Noel, GJ; Teele, DW | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Brogard, JM; Comte, F | 1 |
1 review(s) available for moxalactam and cefaclor anhydrous
Article | Year |
---|---|
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
8 other study(ies) available for moxalactam and cefaclor anhydrous
Article | Year |
---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ocular pharmacokinetics of latamoxef and cefaclor in humans. Penetration into aqueous humor.
Topics: Aged; Aqueous Humor; Cefaclor; Cephalexin; Eye; Female; Humans; Male; Middle Aged; Moxalactam | 1989 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Ocular pharmacokinetics of latamoxef and cefaclor in rabbits. Penetration into aqueous humor.
Topics: Administration, Oral; Animals; Aqueous Humor; Cefaclor; Cephalexin; Injections, Intravenous; Male; Models, Biological; Moxalactam; Protein Binding; Rabbits | 1988 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |